Area of research
Cellular and Molecular Neuroscience · Molecular Biology
Research interest
Research focused on Neuropsychopharmacology and Therapeutic drug monitoring, with related work in Schizophrenia (object-oriented programming), Genetics, Drug. Notable publications include 'Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017', 'TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians', and 'Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response'.
Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis
Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs
Erratum zu: Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians
Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics
Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response
Integrated Pathway-Based Approach Identifies Association between Genomic Regions at CTCF and CACNB2 and Schizophrenia
Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls
Schizophrenia risk polymorphisms in the <i>TCF4</i> gene interact with smoking in the modulation of auditory sensory gating